http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2704977-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc8e1fce359ef4ee5bdc0add916dc5bd |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_764a53520e3eb6bd2c37a0d0bfd97972 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a219781a29f77d8214cb4084e94d3981 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_005a02229b34b5f7203b7dd421398590 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d106d75c4e2105e98fe55157d845422 |
publicationDate | 2019-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2704977-C1 |
titleOfInvention | Method for reducing blood glucose in patients with diabetes mellitus complicated by diabetic foot |
abstract | FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to endocrinology, and concerns developing methods of treating diabetes patients. Method for lowering blood glucose level in patients with diabetes mellitus complicated by a diabetic foot involves intravenous exposure of blood on one hand to a blue laser at wavelength of 450 nm, average emissive power of which at the output of the disposable light guide is not less than 1 mW, with simultaneous ozonation of blood on the vein of the other hand, introducing for this purpose jet of 200 ml of physiological solution, with concentration of ozone in it of 2 mcg/ml. Procedure is performed in a dark room for 15–20 minutes, with the therapeutic course of 10 days.EFFECT: invention provides lowering blood glucose level with subsequent preservation of reduced blood glucose in a prolonged effect, which affects the improvement of patients, namely, improving blood microcirculation and soft tissue wound regeneration, respectively; improved sensitivity of lower extremities.1 cl, 4 tbl, 1 ex |
priorityDate | 2019-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.